US-based healthcare software-as-a-service (SaaS) company Glytec has partnered with the Leapfrog Group, a non-profit healthcare organisation, through its Partner Advisory Committee (PAC).
The partnership aims to help consumers, health professionals and organisations integrate Leapfrog Hospital Survey results into their healthcare decisions and quality initiatives while improving patient safety and outcomes in inpatient diabetes care.
Go deeper with GlobalData
Formed in 2009, the Leapfrog Group’s PAC includes an exclusive set of national and regional health plans, hospital networks and corporate suppliers who provide advice on significant trends within the industry, as well as collaborate on various initiatives driven by partners.
Based in Massachusetts, Glytec provides an SaaS platform for diabetes management and insulin dosing that is used in more than 350 hospitals.
The company aims to work with industry leaders to develop strategies that optimise inpatient diabetes management through the partnership, potentially yielding a high return on investment through reduced costs and increased intensive care bed availability.
Glytec CEO Pat Cua said: “Inpatient diabetes management is a cornerstone of healthcare delivery, with effects that extend beyond hospital walls.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData“By managing diabetes effectively during hospitalisation, we can significantly improve patient outcomes, increase hospital throughput, reduce complication risks, and enhance the overall cost and quality of care.
“Glytec is proud to partner with the Leapfrog Group to advance patient safety and establish a new standard for diabetes care.”
The partnership comes after the US Centers for Medicare & Medicaid Services (CMS) recently mandated hospital reporting on hypoglycaemic and hyperglycaemic events, highlighting the critical nature of diabetes management in hospitals.
Leapfrog Group CEO and president Leah Binder said: “We are thrilled to welcome Glytec to the Partner Advisory Committee!
“Glytec’s expertise in diabetes management and dedication to patient safety will greatly enhance our collaborative efforts to improve cost-effective health care delivery.
“Their participation will provide valuable industry insights that will lead to meaningful advancements in patient care.”
